Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion type Assertion NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_head.
- NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion description "[PFIC types 1 and 2 are characterized by cholestasis and a low to normal serum gamma-glutamyltransferase (GGT) activity, whereas in PFIC type 3, the serum GGT activity is elevated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_provenance.
- NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion evidence source_evidence_literature NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_provenance.
- NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion SIO_000772 10758420 NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_provenance.
- NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion wasDerivedFrom befree-20140225 NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_provenance.
- NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_assertion wasGeneratedBy ECO_0000203 NP350707.RAnf47zduuLkrXcBEbFvY1xnZIkAvgbyYT2HtgOy-xr5o130_provenance.